| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T144 |
0-265 |
Sentence |
denotes |
There were significant differences between the time interval groups after disease onset in proportions of patients with both GGO and consolidation (χ2 = 22.2, p < 0.01) and the combination of GGO, consolidation, and linear opacities (χ2 = 21.5, p < 0.01) (Table 2). |
| T145 |
266-595 |
Sentence |
denotes |
A proportion of patients with GGO and consolidation presented a decreasing trend during the 21 days after disease onset (y = 0.48–0.09x, p < 0.01), while a proportion of patient with all three findings including ground glass opacities, consolidation, and linear opacities presented an increasing trend (y = 0.12–0.11x, p < 0.01). |
| T146 |
596-715 |
Sentence |
denotes |
No significant difference was found in the proportions of patients with other CT findings or total lung severity score. |
| T147 |
716-840 |
Sentence |
denotes |
Table 2 Evolution of CT findings and total lung severity scores of patients with COVID-19 within 21 days after disease onset |
| T148 |
841-891 |
Sentence |
denotes |
Characteristic Time after disease onset χ2 p value |
| T149 |
892-986 |
Sentence |
denotes |
Days 0–3 (n = 37) Days 4–7 (n = 69) Days 8–10 (n = 53) Days 11–14 (n = 49) Days 15–21 (n = 25) |
| T150 |
987-1006 |
Sentence |
denotes |
Pulmonary opacities |
| T151 |
1007-1070 |
Sentence |
denotes |
GGO only 8 (21.6) 13 (18.8) 7 (13.2) 4 (8.2) 1 (4.0) 6.6 0.16 |
| T152 |
1071-1152 |
Sentence |
denotes |
GGO and consolidation 12 (32.4) 26 (37.7) 8 (15.1) 5 (10.1) 1 (4.0) 22.2 < 0.01 |
| T153 |
1153-1229 |
Sentence |
denotes |
GGO and linear opacities 2 (5.4) 2 (2.9) 4 (7.5) 2 (4.1) 2 (8.0) 1.87 0.76 |
| T154 |
1230-1300 |
Sentence |
denotes |
Consolidation only 1 (2.8) 6 (8.7) 3 (5.7) 4 (8.2) 1 (4.0) 1.98 0.74 |
| T155 |
1301-1385 |
Sentence |
denotes |
Consolidation and linear opacities 0 (0) 2 (2.9) 4 (7.5) 4 (8.2) 3 (12.0) 6.0 0.19 |
| T156 |
1386-1490 |
Sentence |
denotes |
GGO, consolidation, and linear opacities 12 (32.4) 19 (27.5) 25 (47.2) 30 (61.2) 17 (68.0) 21.5 < 0.01 |
| T157 |
1491-1553 |
Sentence |
denotes |
Negative CT 2 (5.4) 1 (1.5) 2 (3.8) 0 (0.0) 0 (0.0) 4.3 0.36 |
| T158 |
1554-1568 |
Sentence |
denotes |
Other findings |
| T159 |
1569-1645 |
Sentence |
denotes |
Discrete pulmonary nodules 4 (10.8) 4 (5.8) 3 (5.7) 1 (2.0) 0 (0) 4.8 0.36 |
| T160 |
1646-1698 |
Sentence |
denotes |
Pleural effusion 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) – – |
| T161 |
1699-1750 |
Sentence |
denotes |
Lymphadenopathy 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) – – |
| T162 |
1751-1812 |
Sentence |
denotes |
Cavitation 3 (8.1) 3 (4.3) 1 (1.9) 2 (4.1) 1 (4.0) 2.1 0.72 |
| T163 |
1813-1838 |
Sentence |
denotes |
Total lung severity score |
| T164 |
1839-1907 |
Sentence |
denotes |
Mean ± SD 3.9 ± 2.7 4.8 ± 2.9 4.9 ± 2.8 5.3 ± 3.3 5.2 ± 2.8 – 0.29 |
| T165 |
1908-1973 |
Sentence |
denotes |
Median (range) 4 (0–10) 5 (0–12) 5 (0–11) 5 (1–13) 5 (1–11) – – |
| T166 |
1974-2012 |
Sentence |
denotes |
Numbers in parentheses are percentages |
| T167 |
2013-2061 |
Sentence |
denotes |
n number of patients, GGO ground glass opacities |
